scispace - formally typeset
Open AccessJournal ArticleDOI

Neutrophil Extracellular Traps Affecting Cardiovascular Health in Infectious and Inflammatory Diseases.

Reads0
Chats0
TLDR
Neutrophil extracellular traps (NETs) are web-like structures of decondensed extracellular chromatin fibers and neutrophil granule proteins released by neutrophils.
Abstract
Neutrophil extracellular traps (NETs) are web-like structures of decondensed extracellular chromatin fibers and neutrophil granule proteins released by neutrophils. NETs participate in host immune defense by entrapping pathogens. They are pro-inflammatory in function, and they act as an initiator of vascular coagulopathies by providing a platform for the attachment of various coagulatory proteins. NETs are diverse in their ability to alter physiological and pathological processes including infection and inflammation. In this review, we will summarize recent findings on the role of NETs in bacterial/viral infections associated with vascular inflammation, thrombosis, atherosclerosis and autoimmune disorders. Understanding the complex role of NETs in bridging infection and chronic inflammation as well as discussing important questions related to their contribution to pathologies outlined above may pave the way for future research on therapeutic targeting of NETs applicable to specific infections and inflammatory disorders.

read more

Citations
More filters
Journal ArticleDOI

Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19.

TL;DR: In this paper, the impact of inflammation on platelet activation in atherosclerosis has been investigated and the role of pro-inflammatory cytokines has also been highlighted, such as platelet factor-4, myeloperoxidase, and platelet-derived mediators.
Journal ArticleDOI

Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches

TL;DR: An overview of the available antiplatelet agents is being portrayed, together with agents possessing off-set platelet-inhibitory actions, while an extensive presentation of drugs under investigation is given.
Journal ArticleDOI

Citri Reticulatae Pericarpium (Chenpi): A multi-efficacy pericarp in treating cardiovascular diseases.

TL;DR: In this paper , the authors provide a rigorous and up-to-date overview of the cardiovascular protection properties and potential molecular targets of Citri Reticulatae Pericarpium (CRP), and highlight the pharmacokinetics and therapeutic potential of the main pharmacologically active components of CRP to treat CVDs.
References
More filters
Journal ArticleDOI

Neutrophil extracellular traps induced by IL-8 aggravate atherosclerosis via activation NF-κB signaling in macrophages.

TL;DR: The data reveal a neutrophil-macrophage interaction in AS progression, and indicate that NETs represent as a novel therapeutic target in treatment of AS and other cardiovascular diseases (CVD).
Journal ArticleDOI

α-enolase of Streptococcus pneumoniae induces formation of neutrophil extracellular traps

TL;DR: The results indicate that α-enolase from S. pneumoniae increases neutrophil migrating activity and induces cell death of human neutrophils by releasing neutrophIL extracellular traps.
Journal ArticleDOI

Neutrophil extracellular trap-microparticle complexes enhance thrombin generation via the intrinsic pathway of coagulation in mice.

TL;DR: It is concluded that NET-MP complexes induce thrombin generation via the intrinsic pathway of coagulation and that neutrophil-derived MPs play a key role in NET-dependent coagulations.
Journal ArticleDOI

Neutrophil Extracellular Traps Promote Inflammatory Responses in Psoriasis via Activating Epidermal TLR4/IL-36R Crosstalk

TL;DR: It is demonstrated that NETs drive inflammatory responses in skin through activation of epidermal TLR4/IL-36R crosstalk, and the mechanisms for the proinflammatory activity of NETs in skin are outlined to identify NETs/TLR4 as novel therapeutic targets in psoriasis.
Journal ArticleDOI

Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice.

TL;DR: In diabetic mice deoxyribonuclease 1 (DNase1) treatment reduced plaque NETs content and macrophage inflammation, promoting atherosclerosis resolution after lipid-lowering, and these data suggest that NETs contribute to the increased cardiovascular disease risk in this population and are a potential therapeutic target.
Related Papers (5)